Approval · Notice of Compliance 37005 · 2026
ACETYLCYSTEINE SOLUTION: Notice of Compliance 37005
Issued February 27, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 37005
- Date
- February 27, 2026
- Company
- Sandoz Canada Inc.Saint-Hubert, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- Replacement of a primary container closure system
- Canadian reference product
- MUCOMYST
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ACETYLCYSTEINE SOLUTION | Not yet assigned | — |
Medicinal ingredients
- ACETYLCYSTEINE 200 MG per ML